Related Experiment Video
Updated: May 10, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors
Francesca Cavallo1, Darren R Feldman, Marco Barchi
1Department of Biomedicine and Prevention, University of Rome Tor Vergata, Italy.
Abstract:
Testicular germ cell tumors (TGCTs), ie, seminomas and nonseminomas, account for 1% to 3% of all neoplasms in men. They are the most common cancer in young white males and are unique in their responsiveness to cisplatin-based chemotherapy. For this reason, TGCTs are considered a model for curative disease. However, up to now, the molecular mechanisms behind this exceptional responsiveness to DNA-damaging agents have remained unclear. A hypersensitive apoptotic response, as well as a reduction in the proficiency to repair cisplatin-induced DNA damage might account for this behavior. In this review, building on recent findings of p53-induced apoptosis and DNA-repair mechanisms in TGCTs, we will discuss the molecular bases that drive tumor sensitivity to cisplatin, emphasizing the new therapeutic approaches proposed to eventually constrain tumor recurrence, and target TGCTs which are unresponsive to standard therapies.
Insights
Testicular germ cell tumors (TGCTs) show exceptional sensitivity to cisplatin chemotherapy due to enhanced apoptosis and reduced DNA repair. Understanding these mechanisms may lead to better treatments for recurrent or unresponsive TGCTs.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Testicular germ cell tumors (TGCTs) are the most common cancer in young men and are highly responsive to cisplatin chemotherapy.
- The molecular basis for this exceptional sensitivity to DNA-damaging agents remains largely unclear.
- Potential mechanisms include hypersensitive apoptosis and reduced DNA repair capacity in TGCT cells.
Purpose of the Study:
- To review the molecular mechanisms underlying TGCT sensitivity to cisplatin.
- To discuss the role of p53-induced apoptosis and DNA repair.
- To highlight novel therapeutic strategies for TGCTs, including those unresponsive to standard treatment.
Main Methods:
- Literature review of recent findings on p53-induced apoptosis.
- Analysis of DNA-repair mechanisms in TGCTs.
- Discussion of emerging therapeutic approaches.
Main Results:
- TGCTs exhibit a unique hypersensitive apoptotic response to DNA damage.
- Reduced proficiency in repairing cisplatin-induced DNA damage contributes to sensitivity.
- p53-mediated apoptosis plays a crucial role in this process.
Conclusions:
- Molecular insights into TGCT cisplatin sensitivity involve p53-induced apoptosis and DNA repair pathways.
- Understanding these mechanisms can guide the development of new therapies.
- Targeting these pathways may improve outcomes for recurrent or cisplatin-unresponsive TGCTs.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Overview of DNA Repair
Chemically...
Overview of DNA Repair
Chemically...
Negative Regulator Molecules

